Fin Cascade

Prices as of 8 Oct 2026 close · Not investment advice

Emami Limited

NSE: EMAMILTDPersonal Care

Share price

₹367.25

-2.18% close of 8 Oct 2026

Market cap ₹16,159 CrP/E 21.3

Business score

How strong the business is, in one number. The parts behind it are in Pro.

68

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹16,159 Cr

P/E ratio

21.3

P/B ratio

5.5

ROCE

28.1%

ROE

26.2%

Dividend yield

2.7%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹551.5052-week low ₹363.65

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 2.8% over the past year, and 11.5% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 28.0% to 24.3% over the last four years.

Whether it grew faster than its sector

It grew 11.5% a year against a sector median of 9.9% — 1.5 percentage points faster.

Room to re-rate, or risk of de-rating

At 21.3× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 35.9×, across 5 companies. It is against its own five-year median of 30.8×, the 4th percentile of its own range.

Whether growth justifies the valuation

Priced at 4.3 times its growth rate, on earnings growth of 5%.

Profit growthPrice per ₹1 profitPer 1% growth
Emami Limited — this one5%/yr21.3×₹4.3
Godrej Consumer Products5%/yr42.5×₹8.5
Dabur India4%/yr33.6×₹8.4
Cupid Limited—348.8×—
Colgate-Palmolive India8%/yr34.8×₹4.3
Gillette India Limited31%/yr35.9×₹1.2

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Personal Care), it ranks 6 of 10 on returns, 5 of 10 on growth, 5 of 10 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 28.1% on capital, ahead of 40% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹3869 crore of cash from the business, spent ₹613 crore on plant and equipment, and returned ₹2627 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 131 arrived as cash (before interest, which is why it can exceed the profit). Its cash comes back more slowly than it used to: it went from being waiting 0 days for its cash to waiting 21 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

6 of 9 checks clear · 67%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Sales up 15% but profit down 15% as the tax rate normalised and input costs rose

Announced 4 Aug 2026 · Consolidated · Unaudited

Revenue

₹1,039 Cr

Revenue vs last year

+15.0%

Revenue vs last quarter

+12.3%

Net profit

₹139 Cr

Profit vs last year

-15.3%

Profit vs last quarter

-2.8%

Net margin

13.4%

EPS

₹3.15

Earnings call transcript · 4 Aug 2026

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹16,159 Cr
Prev close
₹367.25
52w High
₹556
52w Low
₹361
Enterprise value
₹15,801 Cr
Beta
0.7
Price CAGR 1y
-31.0%
Price CAGR 3y
-10.0%
Price CAGR 5y
-7.0%
Price CAGR 10y
-4.0%

Ratios

Return on assets
20.2%
PEG ratio
4.2
P/E ratio
21.3
P/B ratio
5.5
EV / EBITDA
16.9
Industry P/E
34.7
ROCE
28.1%
ROCE 5y average
30.2%
ROE
26.2%
Debt / Equity
0.1
Interest coverage
77.9
Dividend yield
2.7%
ROE 3y average
28.0%
ROE last year
26.0%

Annual P&L

Annual revenue
₹3,780 Cr
Annual profit
₹775 Cr
Operating margin
25.0%
Net profit margin
20.5%
EBITDA margin
25.4%
Sales growth 3y
3.5%
Sales growth 5y
5.6%
Profit growth 3y
5.0%
Profit growth 5y
11.0%
EPS
₹17.8
Sales growth TTM
3.0%
Profit growth TTM
-7.0%
Dividend payout
56.0%

Quarter P&L

Sales latest quarter
₹1,039 Cr
Profit latest quarter
₹139 Cr
YoY quarterly sales growth
14.9%
YoY quarterly profit growth
-15.2%
OPM latest quarter
21.6%

Balance Sheet

Book Value
₹66.5
Face Value
₹1.0
Total debt
₹162 Cr
Total cash
₹410 Cr
Borrowings
₹162 Cr
Reserves / Equity
65.5

Cash Flow

Operating cash flow
₹801 Cr
Free cash flow
₹770 Cr
FCF yield
4.7%
Net cash flow
₹72 Cr

Shareholding

Promoter holding
54.8%
FII holding
7.9%
DII holding
27.0%
Public holding
10.3%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Godrej Consumer865.5542.788,5722.31504.510.64,225.515.418.8
Dabur India383.5534.368,0402.15586.215.03,764.410.620.3
Colgate-Palmoliv1,757.4034.947,7992.73343.17.81,603.311.8108.0
Cupid343.95336.646,2500.0044.2194.0157.0142.533.9
Gillette India7,223.5035.223,5412.49159.59.4783.010.890.7
P & G Hygiene6,921.0028.422,4663.32126.3-34.3891.5-4.9157.2
Emami375.4521.616,3882.66138.9-16.41,039.214.928.1
Median454.5538.215,9710.3490.515.0756.015.430.2

Competes with: Bajaj Consumer Care Limited, Colgate-Palmolive India, Cupid Limited, Dabur India, Gillette India Limited, Godrej Consumer Products, Honasa Consumer Limited, JHS Svendgaard Laboratories Limited, Procter & Gamble Hygiene and Health Care Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales8268659968919068911,0499639047991,1529251,039
Expenses636632682682692645715744692622768739815
Material Cost162164200211181215
Change in Inventories184.33-6844-3726
Purchases of Stock-in-Trade1481099983148115
Employee Cost111119121121117136
Other Expenses305294267308330322
Operating Profit190233314209214246334219212177384186225
OPM %23273224242832232322332022
Other Income811111110221521222192318
Exceptional items (within Other Income)000-1000
Interest2233222323336
Depreciation46464648444546444445454243
Profit before tax150196276169178220301194187150345164195
Tax %9861316471612171329
Net Profit137180261147151211279162164148319143139
EPS in Rs3.144.095.923.413.504.876.393.723.763.407.323.283.15
Diluted EPS in Rs3.723.763.407.323.283.15

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,0762,3582,4882,5312,6952,6552,8813,1923,4063,5783,8093,7803,915
Expenses1,5361,6701,7291,8121,9701,9702,0002,2542,5502,6322,7962,8202,943
Material Cost724756
Change in Inventories22-56
Purchases of Stock-in-Trade448438
Employee Cost447479
Other Expenses1,1431,199
Operating Profit5416887597197256858809388559461,014960972
OPM %26293128272631292526272525
Other Income91443119254669906941687572
Exceptional items (within Other Income)0-10
Interest5545834212113571091114
Depreciation34255309311325336367335247186178177176
Profit before tax592423424393403374569688670791894846854
Tax %18142022251920-2268108
Net Profit485363340306303302455837627724803775750
EPS in Rs1187.506.776.686.6710191517181817
Diluted EPS in Rs1818
Dividend Payout %334447526060784255485456

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
5%
5 years
6%
3 years
4%
TTM
3%

Compounded profit growth

10 years
6%
5 years
11%
3 years
5%
TTM
-7%

Stock price CAGR

10 years
-4%
5 years
-7%
3 years
-10%
1 year
-31%

Return on equity

10 years
26%
5 years
31%
3 years
28%
Last year
26%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital232323234545444444444444
Reserves1,2081,5891,7321,9912,0311,7781,7182,0322,2592,4032,6512,880
Borrowings36671473326110210101282919490162
Other Liabilities410409376458633644656692703728741745
Minority Interest-1.43-1.54
Total Liabilities1,6762,6922,6032,7982,8192,6782,5203,0503,0963,2693,5253,831
Fixed Assets4531,9181,9941,8021,6801,4591,1321,3441,2451,114984886
CWIP296722303686368151
Investments501104128314187156255303293442676834
Other Assets6936044606529151,0551,1261,4001,5511,7061,8502,108
Total Assets1,6762,6922,6032,7982,8192,6782,5203,0503,0963,2693,5253,831

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity534562730588554531922644749779896801
Cash from Investing Activity-237-1,313-306-276-26-231-224-234-122-210-345-174
Cash from Financing Activity-215502-496-324-428-405-688-402-608-563-500-554
Net Cash Flow82-249-72-12100-106981965272
Free Cash Flow426430448465421383890164719750852771

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days182014222942293744504333
Inventory Days596883878810211812110010294128
Days Payable9011285109115135138138124143133153
Cash Conversion Cycle-13-2412129101920948
Working Capital Days-16-54-62-32-67-3028302521
ROCE %613023221918293128323228

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters555555555555555555555555
FIIs1213131414141212119.038.577.87
DIIs252422222222242425272727
Public8.058.359.639.539.279.369.389.219.229.409.6710
No. of Shareholders79,21682,15191,33497,2581,27,8971,28,7251,29,0021,26,5991,26,7761,29,0771,27,6151,31,617

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -32.2% (₹541.70 → ₹367.25)Brick size ₹11.74 (fixed)Bricks 34
₹400₹450₹500₹367Dec '25Feb '26Apr '26Jun '26Aug '26
Price moved up one brickPrice moved down one brickLast close ₹367.25 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

98,42,622inr

2026-03-31

News

News and filings about Emami Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Uses as raw material

  • HDPE/LDPE & laminate packaging
  • Hard paraffin / microcrystalline (MC) wax
  • Light liquid paraffin (LLP) — Navratna/BoroPlus base
  • Medicinal & aromatic herbs (ashwagandha, tulsi, lemongrass, kaunch, vasak, etc.)
  • Menthol / mentha oil
  • Methyl salicylate
  • Stearic acid / fatty acids

Depends on the price of

  • Crude Oil Brent
  • Medicinal Herbs
  • mentha

Sells to

Buys from

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Fast Moving Consumer Goods
Industry
Personal Care
Classification
Fast Moving Consumer Goods › Personal Care
ISIN
INE548C01032

Plants

  • Emami Amingaon (Guwahati) unit
  • Emami Masat unit
  • Emami Pacharia unit
  • Emami Pantnagar unit
  • Emami Vapi unit

News impact

Big market events that reach Emami Limited, and how the effect spreads.

Who it hits first

  • Cupid raised its FY27 targets for the second time in two weeks, now guiding Rs 800 crore revenue and Rs 250 crore net profit.
  • Shares hit a fresh 52-week high, extending a 617% one-year run on strong home and export demand.
  • No other company's earnings change: the raise covers Cupid's own orders only.

Who may gain

  • Cupid shareholders, who see higher expected earnings and a fresh 52-week high
  • Cupid distributors and export partners, if higher volumes flow through their channels
  • No peer beneficiary: rival consumer-goods makers gain no sales from Cupid's own targets

Along the supply chain

Downstream

Distributors and export agents handling Cupid's products move higher volumes as the raised targets turn into shipments.

Upstream

Mild upstream pull: if Cupid makes more goods, its raw-material and packaging suppliers see slightly bigger orders.

Where demand moves

Business

Real product demand: buyers at home and abroad are ordering more of Cupid's goods, which is why its targets rose twice in two weeks.

Capital

Growth money chases the raise, bidding Cupid to a 52-week high; peers see no spillover inflows since their earnings are untouched.

How it spreads across sectors

Fast Moving Consumer Goods

Neutral: large consumer-goods makers share no shelf or tender with Cupid's niche, so no sales spill over.

Healthcare

Positive but narrow: one small company's beat lifts sentiment without changing hospital, lab or pharma demand.

When it plays out

Immediate

Cupid extends gains over 1-7 days as the raise sinks in; peers drift with the market.

Medium term

Over 1-6 months Cupid must convert guidance into quarterly numbers; any miss would unwind the premium fast.

Short term

Over 1-4 weeks Cupid consolidates near highs unless buyers keep chasing; profit-booking risk grows after 617%.

Who it hits first

  • Cupid Limited, a small maker of personal-care and contraceptive goods, jumped 10% to Rs 291 on news that it joins the Nifty Smallcap 250 index from September 30.
  • Joining the index means mutual funds and exchange-traded funds that copy that index (called passive funds) must buy Cupid shares, creating a one-off wave of forced buying.
  • The stock has already surged 250% in six months, and strong June-quarter results plus higher FY27 guidance give buyers a growth story beyond the index news.
  • No factory, order, or sales change is involved — this is purely a money-flow event, not a business event.

Who may gain

  • Cupid's existing shareholders, who gain as forced index buying pushes the share price up.
  • Cupid Limited itself, which gets more visibility and easier future fundraising as an index stock.
  • Short-term traders who bought before the announcement and can sell into the passive demand.

Along the supply chain

Downstream

No direct supply-chain link downstream — distributors and retailers see no change in product flow from a stock-market event.

Upstream

No direct supply-chain link upstream — index inclusion does not change Cupid's raw-material or packaging orders.

Where demand moves

Business

No change in business demand — shops do not order more Cupid products because the stock joined an index; sales depend on the June-quarter momentum and guidance, not the listing.

Capital

Positive capital demand for Cupid only — passive funds that copy the Nifty Smallcap 250 must buy the stock around September 30, and active traders front-running that bid amplified the 10% pre-move.

How it spreads across sectors

Fast Moving Consumer Goods

Neutral for peers — Godrej Consumer, Dabur, Emami, Colgate and other personal-care makers get no order or money-flow spillover from Cupid's inclusion.

Healthcare

Negligible — a single-stock index-flow event with no change in healthcare demand, pricing, or regulation.

When it plays out

Immediate

September 30 inclusion day: forced passive buying, high volume, and a choppy price as pre-positioned traders sell into the index bid.

Medium term

1–6 months: index status stops mattering; only earnings delivery against the raised guidance and the stretched valuation decide the path.

Short term

1–4 weeks: tracking settles, the index premium fades, and the price drifts on profit-taking versus the FY27 guidance story.

29 Sept, 10:17 IST · Market event · high impact

Honasa Consumer Share Price Falls Over 3% On Block Deal Buzz

Early investors plan to sell up to 89 lakh Honasa shares in a block deal, so Honasa shares fell over 3%, hurting current holders while block buyers may get a discount and rivals see no change.

Fast Moving Consumer Goods

Who it hits first

  • Honasa Consumer, which sells Mamaearth beauty and baby-care products, fell over 3% after news that early backers may sell up to 89 lakh shares in one block trade.
  • Peak XV Partners, Sequoia Capital Global Growth Fund III and Redwood Trust are the likely sellers, cashing out part of their early stake.
  • A big sale like this adds many shares for sale at once, so the price dips until new buyers absorb the block.

Who may gain

  • Block-deal buyers, who may pick up Honasa shares at a discount to the market price
  • Short-term traders who sold early on the buzz and can buy back lower after the sale
  • Patient buyers who want Honasa for its brands and get a cheaper entry on the dip

Along the supply chain

Downstream

No downstream change — Nykaa, the beauty retailer that sells Honasa products, sees the same shopper demand; only Honasa's share price moves.

Upstream

No upstream change — software and order-service providers to Honasa see no order change when investors sell shares.

Where demand moves

Business

No change in shop demand — people buy the same Mamaearth creams and shampoos; only share ownership changes hands.

Capital

Selling pressure on Honasa shares — up to 89 lakh shares offered in the block must find new buyers, so the price slips until the block clears.

How it spreads across sectors

Fast Moving Consumer Goods

No real ripple — a single-company share sale does not change soap, cream or shampoo sales for Dabur, Godrej Consumer, Emami or Colgate.

When it plays out

Immediate

In 1-7 days, Honasa stays weak as the 89-lakh-share block hangs over the price and clears.

Medium term

In 1-6 months, price follows business — Mamaearth growth and profits matter, not the old investor exit.

Short term

In 1-4 weeks, shares steady once the block finds buyers and focus returns to sales and margins.

15 Sept, 05:00 IST · Market event · medium impact

Emami board to consider share buyback on September 17

Ayurveda products maker Emami may announce buying back its own shares on September 17 — usually a quick boost for the stock.

Fast Moving Consumer Goods

Who it hits first

  • Emami stock rallies 2-4% into the Sep-17 board meet on buyback expectations.
  • A confirmed buyback shrinks share count and lifts per-share earnings and price.
  • FMCG peers see no fundamental impact — pure sentiment markers.

Who may gain

  • Emami shareholders: buyback price support plus reduced share count.

Along the supply chain

Downstream

Distributors and retailers see zero impact from a board buyback decision.

Upstream

No direct supply-chain link — a capital-allocation event, not an operations event.

Where demand moves

Business

No business-demand change — this is capital return, not operations; traders supply event liquidity.

Capital

Money rotates into Emami for the event; record-date arbitrage follows if confirmed.

How it spreads across sectors

Fast Moving Consumer Goods

No ripple — single-company capital return with no peer read-through.

When it plays out

Immediate

Emami up 2-4% into Sep 17; peers flat.

Medium term

Executed buybacks support the price for quarters via a smaller share count.

Short term

Board decision day decides all: confirm (rally extends) or defer (full unwind).

Who it hits first

  • HONASA: HONASA (Mamaearth): direct listed D2C beauty competitor faces sharper L'Oreal heat. PE 65.1 >> FMCG median 25.7 (premium); ROE 15.7 above 11.4; pledge 4.2%.

Who may gain

  • HINDUNILVR: HUL premium beauty validation. PE 33.5 above FMCG median 25.7; ROE 31.0 well above 11.4. Lakme/Dove portfolio benefits from category premiumisation.
  • DABUR: DABUR ayurvedic + beauty portfolio. PE 39.7 above FMCG median 25.7; ROE 17.2 above 11.4.
  • EMAMILTD: EMAMI premium personal care exposure. PE 25.0 at FMCG median 25.7; ROE 30.2 well above 11.4.

Along the supply chain

Downstream

NYKAA distribution channel benefits from Innovist brand growth; e-commerce volume growth; influencer/MarTech (AFFLE) benefits from increased beauty ad spend.

Upstream

Specialty chemicals (FINEORG, AARTIIND) and fragrance ingredient makers benefit from L'Oreal scaling Innovist with global supply chain.

Where demand moves

Business

L'Oreal majority in Innovist (Bare Anatomy) intensifies premium D2C beauty competition. HONASA Mamaearth faces direct pressure. NYKAA dual-edged: category growth positive, brand-side competition negative. Listed FMCG (HUL, DABUR, EMAMI) gain category premium validation.

Capital

Capital flows into premium beauty validation names — NYKAA, HONASA mixed; HUL premium-beauty exposure (Lakme, Dove, Pond) gets re-rating support. D2C-focused specialty chemicals (FINEORG, CLEAN) may see investor interest.

How it spreads across sectors

Beauty & Personal Care

M&A premium for D2C beauty assets

D2C

Exit liquidity validated — early-stage VCs see clearer exit pathway

FMCG

D2C premium beauty acquisition validates HUL, DABUR Vatika premium bet

codex additions

Commodity angle

Cc skip reason

no_commodity_link

When it plays out

Immediate

HONASA -3-5% on competitive intensity; NYKAA mixed (+/-1-2%); HUL, DABUR +1-2% sympathy.

Medium term

India premium beauty TAM doubles 2026-2028; consolidation cycle continues with more global PE/strategic interest.

Short term

Q1FY27 D2C beauty commentary will reveal L'Oreal-Innovist's pricing strategy — sustained re-rating or fade.

Other sectors it reaches

  • {"causal_chain":"Premium beauty consolidation raises demand for differentiated actives, surfactants, aroma chemicals, preservatives and formulation inputs as large strategics scale acquired D2C brands.","direction":"positive","example_tickers":["FINEORG","AARTIIND","CLEAN"],"magnitude":"medium","notes":"Benefit is indirect and depends on domestic sourcing versus imported formulations.","sector":"Specialty Chemicals \u0026 Fragrance Ingredients","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Beauty and personal-care premiumization increases need for tubes, pumps, labels, cartons, rigid plastics and sustainable packaging as brands upgrade shelf appeal and omnichannel formats.","direction":"positive","example_tickers":["UFLEX","HUHTAMAKI","EPL"],"magnitude":"medium","notes":"EPL has direct relevance through laminated tubes used in oral care, beauty and personal care.","sector":"Packaging","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Global FMCG buyers acquiring Indian D2C brands may outsource incremental production before investing in captive capacity, lifting demand for third-party formulation and manufacturing partners.","direction":"positive","example_tickers":["HINDUNILVR","GODREJCP","JYOTHYLAB"],"magnitude":"small","notes":"Few pure-play listed beauty contract manufacturers exist on NSE, so tickers are imperfect proxies through consumer manufacturing exposure.","sector":"Contract Manufacturing / CDMO for Consumer Products","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Strategic validation of D2C beauty increases paid discovery, marketplace launches, brand-store investments and online assortment expansion across premium personal care.","direction":"positive","example_tickers":["NYKAA","INDIAMART","MSTCLTD"],"magnitude":"medium","notes":"NYKAA is mixed: competitive pressure from L'Oreal-controlled brands, but category traffic and GMV validation are supportive.","sector":"E-commerce Marketplaces \u0026 Online Retail Enablement","time_horizon":"immediate"}
  • {"causal_chain":"Beauty D2C brands rely heavily on influencer marketing, performance ads, CRM and content commerce; acquisition-driven competition can raise customer-acquisition spending across the category.","direction":"positive","example_tickers":["AFFLE","NAZARA","TIPSFILMS"],"magnitude":"small","notes":"Listed proxies are broad digital media/ad-tech plays rather than beauty-specific vendors.","sector":"Digital Advertising \u0026 MarTech","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Premium beauty brands compete through creator-led education, celebrity collaborations, reels, tutorials and launch campaigns, increasing spend on digital content and influencer ecosystems.","direction":"positive","example_tickers":["SAREGAMA","TIPSINDLTD","ZEEL"],"magnitude":"small","notes":"Impact is diffuse and more visible in campaign activity than near-term earnings.","sector":"Media, Influencer \u0026 Entertainment Platforms","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Scaling D2C beauty requires faster fulfillment, returns handling, marketplace warehousing and cold/controlled storage for certain formulations, supporting third-party logistics demand.","direction":"positive","example_tickers":["DELHIVERY","TCI","BLUEDART"],"magnitude":"small","notes":"Beauty is a small share of total logistics volumes, but high SKU complexity makes the category operationally relevant.","sector":"Logistics \u0026 Warehousing","time_horizon":"1_to_6_months"}
  • {"causal_chain":"D2C beauty brands that receive strategic backing often move from online-only to omnichannel kiosks, shop-in-shops and mall stores, lifting demand for premium retail space.","direction":"positive","example_tickers":["PHOENIXLTD","PRESTIGE","DLF"],"magnitude":"small","notes":"More relevant for premium malls and high-street retail than broad real estate.","sector":"Retail Real Estate / Malls","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Large FMCG-led acquisitions validate consumer-brand M\u0026A, potentially increasing deal financing, advisory mandates, founder liquidity and wealth-management flows.","direction":"positive","example_tickers":["ICICIBANK","KOTAKBANK","AXISBANK"],"magnitude":"small","notes":"Likely modest unless it triggers a broader consumer D2C transaction cycle.","sector":"Private Banks \u0026 Investment Banking / Wealth","time_horizon":"1_to_6_months"}

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

10 Feb 2026interim₹6
14 Nov 2025interim₹4
22 May 2025special₹2
4 Feb 2025interim₹4
18 Nov 2024interim₹4
16 Feb 2024interim₹4
15 Nov 2023interim₹4
13 Feb 2023interim₹4

Splits, bonuses & buybacks

  • daily-prices repair: 14 rows from NSE's archive (replace 6, delete 1, insert 7), 2016-02-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Feb 2016

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.